Liver Diseases and Conditions - Fatty Liver; Researchers from St. Louis University Detail New Studie...
Liver Diseases and Conditions - Fatty Liver; Researchers from St. Louis University Detail New Studies and Findings in the Area of Fatty Liver (Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease)
About this item
Full title
Publisher
Atlanta: NewsRx
Journal title
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
According to the news reporters, the research concluded: "Further characterization of the specificity of GSK2033 revealed that it displayed a significant degree of promiscuity, targeting a number of other nuclear receptors that could clearly alter hepatic gene expression."
Alternative Titles
Full title
Liver Diseases and Conditions - Fatty Liver; Researchers from St. Louis University Detail New Studies and Findings in the Area of Fatty Liver (Promiscuous activity of the LXR antagonist GSK2033 in a mouse model of fatty liver disease)
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1844978543
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1844978543
Other Identifiers
ISSN
1531-6386
E-ISSN
1532-4664
